T-Net: Home

Member Login
|
Employer Login

BC Tech News ▼
International ▼
Member Tools ▼
- Subscribe to T-Net Direct
Submit News ▼

« Sections »
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
« Account Login »
Members
Employers
« Services »
Post Job Listings
Browse Jobs
Advertise

News By Company

News By Company
Xenon Pharmaceuticals Inc.

1 - 10 of 43 Results

New Search

Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs

Burnaby, BC, December 16, 2020--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced updates on its proprietary and partnered neurology programs at AES2020, the virtual Annual Meeting of the American Epilepsy Society.

Snapshot | Profile | News | Follow

Company Snapshot

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)
50-99 Employees In BC (50-99 Employees Total)
Founded: 1987 | Revenues: $15.60 Million

XENON® (NASDAQ: XENE) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform.

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Receives FDA Feedback and is on Track to Initiate XEN496 Phase 3 Clinical Trial for the Treatment of KCNQ2-DEE

Burnaby, BC, October 9, 2020--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a neurology-focused biopharmaceutical company, provided regulatory updates on its proprietary pediatric neurology program, XEN496, a Kv7 potassium channel modulator that is a proprietary pediatric formulation of the active ingredient ezogabine being developed for the treatment of KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE).

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Appoints Dr. Chris Von Seggern as Chief Commercial Officer

Burnaby, BC, August 25, 2020--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a neurology-focused biopharmaceutical company, announced the appointment of Dr. Chris Von Seggern as Chief Commercial Officer, effective immediately.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Burnaby, BC, August 13, 2020--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a neurology-focused biopharmaceutical company, reported its financial results for second quarter ended June 30, 2020 and provided a corporate update.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

Burnaby, BC, May 28, 2020--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a neurology-focused biopharmaceutical company, reported its financial results for first quarter ended March 31, 2020 and provided a corporate update.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Burnaby, BC, March 31, 2020--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical stage biopharmaceutical company, announced equity inducement grants to eight new non-officer employees consisting of an aggregate of 63,200 share options.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Reports 2019 Financial Results and Provides Corporate Update

Burnaby, BC, March 9, 2020--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical stage biopharmaceutical company, reported its financial results for the year ended December 31, 2019 and provided a corporate update.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate Update

Burnaby, BC, January 15, 2020--enon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical stage biopharmaceutical company, provided a corporate update and outlined its key milestone opportunities for 2020.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting

Burnaby, BC, December 12, 2019--Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical stage biopharmaceutical company, announced that it will provide updates on its proprietary, neurology programs at the American Epilepsy Society (AES) Annual Meeting held in Baltimore, MD.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Burnaby-based Xenon and Neurocrine Biosciences Announce Massive Deal to Develop Treatments for Epilepsy (Worth Potential $1.7 Billion)

Burnaby, BC, December 4, 2019--Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and (Nasdaq: XENE) announced a monster license and collaboration agreement to develop first-in-class treatments for epilepsy.

Snapshot | Profile | News | Follow

Company Snapshot

See Full Profile

Company Alert

Xenon Pharmaceuticals Inc.

Burnaby, BC (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

1 2 3 4 5

Hiring Today

See All Jobs

Latest Tech Jobs

Featured Job: RF Technician

Orbital Research Ltd.

QA Engineer II

Conexiom

Mechanical Design Engineer

Zinc8 Energy Solutions

Software Developers

Teradici Corporation

Program Analyst

Maximus Canada

See All Jobs

Registration on or use of this website constitutes acceptance of our Terms of Use.

News
BC Tech News ▼
- Local BC Tech News
- One Week View
- Subscribe to T-Net Direct
International ▼
- All Breaking International Tech News
- Tech Crunch
- Silicon Alley Insider
- VentureBeat
- CNET
Member Tools ▼
- Subscribe to T-Net Direct
Submit News ▼
- Post News Release on T-Net
- Submit Anonymous News Tip
- T-Net News Submission Guidelines
Account
Member Login
Employer Login
Sections
News
- BC Tech News ▼
- International ▼
- Member Tools ▼
  - Subscribe to T-Net Direct
- Submit News ▼
Events
- All BC Tech Events
- Member Tools ▼
- Post Events ▼
Tech Careers
- Tech Careers Home
- Job Search ▼
- Hot Job of the Week TM
- Post Resume ▼
  - Post Resume
  - Create Cover Letter
- Member Tools ▼
- Employers ▼
  - Employer Login
  - Post New Job
Directory
- Tech Directory Home
- Companies ▼
- Suppliers ▼
- Associations ▼
- Add Profile ▼
Tech Stocks
T-Net 100
- T-Net 100 Rankings ▼
- Sector Rankings ▼
- Advertising
Members
- Member Home ▼
- News ▼
- Events ▼
- Careers ▼
- Directory ▼
- Other ▼
Feedback
About T-Net
Services
Post Job Listings
Advertise on T-Net